Success Story: EB1A Approval in just 17 days for an Infectious Disease Epidemiologist from Ethiopia under Premium Processing
Client’s Testimonial:
“I would like to thank the entire team @ CHEN for an excellent job and successful completion of this journey.”
On November 5th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for an Expert in the Field of Infectious Disease Epidemiology (Approval Notice).
General Field: Infectious Disease Epidemiology
Country of Origin: Ethiopia
State of Residence at the Time of Filing: Pennsylvania
Approval Notice Date: November 5th, 2025
Processing Time: 17 days (Premium Processing Requested)
Case Summary:
We are delighted to share the approval of an EB-1A petition for a technical TB/HIV advisor from Ethiopia in the field of infectious disease epidemiology, whose groundbreaking work in tuberculosis and HIV research has positioned them among the field’s most influential scholars. USCIS approved the petition in just 17 days without RFE under premium processing.
Leveraging our proven track record of over 32,000 successful cases, we developed a comprehensive legal strategy that showcased the client’s exceptional qualifications under the most rigorous immigration standards.
Our Strategic Framework:
The client’s expertise, encompassing TB surveillance, HIV treatment adherence, and public health program development, presented a compelling narrative of national importance. We recognized immediately that this M.D. and M.P.H.-trained researcher’s contributions directly strengthen the United States’ capacity to combat infectious disease threats and inform evidence-based health policy.
Our petition emphasized the remarkable scope of the client’s scholarly impact: 36 peer-reviewed articles and 16 conference abstracts published in premier journals. We demonstrated that the client’s work has generated 2,155 citations, securing a ranking in the top 1% of authors.
We carefully documented the client’s standing as a trusted evaluator in the scientific community, having completed 20 peer reviews for distinguished journals and serving in editorial leadership roles. The petition highlighted major funding from the U.S. Agency for International Development, the World Bank, and the CDC’s PEPFAR program, concrete validation of the research’s strategic significance.
Four recommendation letters, including two from independent experts who have cited and built upon the client’s published findings, provided a compelling third-party endorsement. One expert has stated that:
“Given [The Client]’s research contributions, professional accomplishments, and leadership in peer review, [The Client]’s presence in the United States would be of immense value to both research activities and practical applications.”
Results:
The approval of this EB-1A petition confirms the client’s place among the small percentage of researchers who have risen to the top of the field of infectious disease epidemiology. The client’s ongoing work will continue to contribute directly to national and global health by improving TB/HIV detection systems, shaping evidence-based public health policies, and strengthening disease-control infrastructure. NAILG is proud to have represented the client in this successful petition and looks forward to the continued impact of this work on global infectious disease prevention and public health advancement.